Login

Kuvera co-founder Neelabh Sanyal invests 80% of his portfolio in equities through index funds.|Gaurav Rastogi is the CEO of Kuvera 00:10:00

Share On Facebook Share On Twitter

Gaurav Rastogi is the CEO of Kuvera

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Discuss a different side of InsureTech the funding of it|Jon Soberg,Managing Partner,MS&AD Ventures
00:10:00
Tailored Financial Advice: Matching Client Needs with Expertise
00:10:00
James Femia of Apella illustrates how a student's performance can positively impact the type of college financing they receive.|Patrick A. Sweeny is a founding partner of Apella Capital.
00:10:00
David Stein Discusses Investing in Junior Mining and Kuya Silver's Strategy
00:10:00
Basic Game Theory Teaches Us About Startups|Michael Seibel,Managing Director, Early Stage and Group Partner,Y Combinator
00:00:00
Dr. Scott Cheney talks about benign prostatic hyperplasia - Scott M. Cheney, M.D.
00:10:00
Quick Commands Feature Tutorial - Defense IA 3 Software - i2515 | Jorge Luiz Savi de Freitas - Chairman of Intelbras SA Industria de Telecomunicacao Eletronica Brasileira
00:10:00
Gold Exploration Funding: Trends, Risks, and Investor Sentiment
00:10:00
Debating the Legacy of Leon Trotsky: Insights from Hitchens and Service|Robert W. Service
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:00:00
Judy C. Boughey, M.D. Surgical Oncologist, Mayo Clinic
00:10:00
Exploration Potential of Wallbridge's Gold Projects

© 2026 Nehu